Ligand Pharmaceuticals Incorporated
LGND
$193.03
-$2.07-1.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 202.55% | 7.97% | -32.74% | 50.41% | 15.30% |
| Total Receivables | 19.22% | 35.45% | 70.55% | 7.98% | 35.35% |
| Inventory | -28.91% | -17.05% | -31.51% | -41.12% | -34.07% |
| Prepaid Expenses | -- | -- | -- | 63.62% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -20.07% | 53.64% | 597.73% | 535.94% | 1,057.56% |
| Total Current Assets | 143.68% | 13.03% | -16.15% | 39.65% | 21.81% |
|
|
|||||
| Total Current Assets | 143.68% | 13.03% | -16.15% | 39.65% | 21.81% |
| Net Property, Plant & Equipment | -56.04% | -54.34% | -56.97% | -1.02% | -3.03% |
| Long-term Investments | -3.52% | -3.52% | -3.52% | 1.82% | 1.43% |
| Goodwill | -3.52% | -3.52% | -3.52% | 1.82% | 1.43% |
| Total Other Intangibles | -15.05% | -11.66% | -11.33% | -11.00% | -14.48% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.44% | 74.24% | 179.18% | 179.73% | 1,238.64% |
| Total Assets | 54.66% | 9.49% | -0.92% | 19.63% | 24.13% |
|
|
|||||
| Total Accounts Payable | -21.62% | 378.75% | 183.47% | 115.62% | 89.66% |
| Total Accrued Expenses | 56.60% | 54.04% | 166.67% | 153.01% | 64.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.09% | -4.71% | -11.96% | 214.63% | 119.32% |
| Total Finance Division Other Current Liabilities | -12.16% | 587.61% | 347.60% | 31.26% | 22.48% |
| Total Other Current Liabilities | -12.16% | 587.61% | 347.60% | 31.26% | 22.48% |
| Total Current Liabilities | 23.28% | 248.69% | 229.35% | 121.14% | 57.51% |
|
|
|||||
| Total Current Liabilities | 23.28% | 248.69% | 229.35% | 121.14% | 57.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.55% | -27.84% | -31.76% | 1.56% | 7.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -44.16% | -23.43% | -43.48% | 7.23% | 3.61% |
| Total Liabilities | 363.20% | 31.65% | 2.38% | 29.00% | 12.20% |
|
|
|||||
| Common Stock & APIC | 17.22% | 50.13% | 56.02% | 69.79% | 68.12% |
| Retained Earnings | 9.08% | -14.12% | -22.51% | -0.80% | 9.33% |
| Treasury Stock & Other | 433.91% | 1,008.45% | -71.76% | -627.29% | 284.96% |
| Total Common Equity | 12.96% | 6.88% | -1.36% | 18.48% | 25.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.96% | 6.88% | -1.36% | 18.48% | 25.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.96% | 6.88% | -1.36% | 18.48% | 25.94% |
|
|
|||||